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Mycobacterium avium subspecies paratuberculosis is the causative agent of Johne’s disease, an intestinal disease of
ruminants with major economic consequences. Infectious bacilli are phagocytosed by host macrophages upon
exposure where they persist, resulting in lengthy subclinical phases of infection that can lead to immunopathology
and disease dissemination. Consequently, analysis of the macrophage transcriptome in response to M. avium subsp.
paratuberculosis infection can provide valuable insights into the molecular mechanisms that underlie Johne’s
disease. Here, we investigate pan-genomic gene expression in bovine monocyte-derived macrophages (MDM)
purified from seven age-matched females, in response to in vitro infection with M. avium subsp. paratuberculosis
(multiplicity of infection 2:1) at intervals of 2 hours, 6 hours and 24 hours post-infection (hpi). Differentially
expressed genes were identified by comparing the transcriptomes of the infected MDM to the non-infected control
MDM at each time point (adjusted P-value threshold ≤ 0.10). 1050 differentially expressed unique genes were
identified 2 hpi, with 974 and 78 differentially expressed unique genes detected 6 and 24 hpi, respectively.
Furthermore, in the infected MDM the number of upregulated genes exceeded the number of downregulated
genes at each time point, with the fold-change in expression for the upregulated genes markedly higher than that
for the downregulated genes. Inspection and systems biology analysis of the differentially expressed genes revealed
an enrichment of genes involved in the inflammatory response, cell signalling pathways and apoptosis. The
transcriptional changes associated with cellular signalling and the inflammatory response may reflect different
immuno-modulatory mechanisms that underlie host-pathogen interactions during infection.Introduction
Johne’s disease in ruminants is caused by infection with
the facultative intracellular pathogen Mycobacterium
avium subspecies paratuberculosis-a mycobacterial spe-
cies closely related to M. tuberculosis and M. bovis, the
causative agents of human and bovine tuberculosis, re-
spectively [1]. Johne’s disease is characterised by chronic
granulomatous enteritis, persistent diarrhoea, progressive
wasting and can result in death. However, M. avium
subsp. paratuberculosis infection often remains asymp-
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reproduction in any medium, provided the orrendering diagnosis difficult [2,3]. Diagnosis is further
confounded by the documented technical limitations of
current diagnostic tests, which are based on faecal cul-
ture techniques, enzyme immunoassays that detect the
presence of milk and serum antibodies directed against
M. avium subsp. paratuberculosis antigens, and inter-
feron-gamma (INF-γ) release assays [4,5].
M. avium subsp. paratuberculosis infection has major
implications for domestic animal health worldwide caus-
ing significant economic loss in affected herds due to
lost productivity and premature culling. In cattle, Johne’s
disease results in estimated losses of $1.5 billion to the
US dairy industry annually, while dairy herd prevalence
of Johne’s disease is estimated ≥ 50% in certain US states
and European countries [6-9]. Furthermore, M. aviumal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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agent that causes or exacerbates Crohn’s disease in
humans; although this hypothesis remains highly con-
tentious [10].
Exposure to M. avium subsp. paratuberculosis in rumi-
nants generally occurs within the first months of life,
through either a faecal–oral route or by ingestion of
infected colostrum or milk, while some evidence sug-
gests that infection can occur in utero [2,3,11,12]. Once
internalised, infectious bacilli cross the intestinal mucosa
by penetrating the M cells that cover the ileal Peyer’s
patches. The bacilli are then phagocytosed by intestinal
macrophages, which serve as key effector cells in initiat-
ing the appropriate innate and adaptive immune re-
sponse necessary to determine the outcome of infection
[13,14].
The immune response to M. avium subsp. paratuber-
culosis infection in ruminants is similar to that elicited
by M. tuberculosis and M. bovis infection in humans and
cattle, respectively [13]. Infected macrophages secrete
several NF-κB-inducible inflammatory cytokines, such as
tumour necrosis factor (TNF-α), interleukin 10 (IL-10)
and interleukin 12 (IL-12), which initiate and regulate an
adaptive immune response characterised by the release of
IFN-γ from T-cells [15-17]. IFN-γ activates microbicidal
activity in infected macrophages and also promotes the se-
questration of the pathogen in granulomas-organised
complexes of immune cells consisting of lymphocytes,
non-infected macrophages and neutrophils that contain
mycobacterial-infected macrophages and prevent the
spread of bacilli to other tissues [1,13].
In many cases, however, the pathogen can evade the
host immune response, resulting in its survival and
propagation in infected macrophages within granulomas.
This persistence can lead to a lengthy non-shedding sub-
clinical phase of between 2–5 years during which M.
avium subsp. paratuberculosis proliferates in the gut,
ultimately resulting in the development of immuno-
pathology that enables the dissemination of infection to
other tissues and shedding from the host [18,19]. The
survival of the pathogen in intestinal macrophages is
believed to be achieved through a diverse range of
mechanisms including the inhibition of phagosome ma-
turation and the suppression of key immuno-regulatory
pathways that mediate the host immune response to
infection [20,21]. Therefore, analysis of the macrophage
transcriptome in response to M. avium subsp. paratu-
berculosis infection may offer a deeper understanding of
the cellular processes governing pathogen-macrophage
interactions and how modulation of these cellular path-
ways can result in pathology. Furthermore, identification
of transcriptional markers of infection may enable novel
diagnostics for Johne’s disease, providing new tools for
disease management.On-going developments in mammalian genome
resources and high-throughput genomic technologies
continually provide improved methodologies for analysis
of the gene expression changes induced in bovine macro-
phages and peripheral blood in response to M. avium
subsp. paratuberculosis infection both in vivo and in vitro
[17,22-25]. In the current study, we analyse genome-wide
transcriptional changes in purified monocyte-derived
macrophages (MDM) isolated from seven Holstein-
Friesian females in response to M. avium subsp. paratu-
berculosis infection in vitro (multiplicity of infection
(MOI) 2:1). Total cellular RNA was extracted from
infected and non-infected control MDM from all seven
animals at intervals of 0, 2, 6 and 24 hpi and prepared for
global gene expression analyses using the pan-genomic
high-density AffymetrixW GeneChipW Bovine Genome
Array. Differentially expressed genes were identified
through comparison of the transcriptional profiles from
the infected and non-infected control MDM at each time
point post-infection. Differentially expressed genes were
further investigated using the IngenuityW Systems Pathway
Analysis (IPA) Knowledge Base in order to identify the
macrophage cellular pathways underlying M. avium subsp.
paratuberculosis infection. These data add a novel layer of
information regarding the complex macrophage molecular
pathways elicited upon M. avium subsp. paratuberculosis
infection and the role these pathways play in establishing
the host immune response to Johne’s disease.Material and methods
Ethics statement
All animal procedures were carried out according to the
provisions of the Cruelty to Animals Act (Irish Department
of Health and Children licence number B100/3939) and
ethical approval for the study was obtained from the UCD
Animal Ethics Committee (protocol number AREC-P-07-
25-MacHugh).Animals
Seven age-matched (four-year old) Holstein-Friesian
females were used in the current study (animal numbers
700, 706, 713, 716, 721, 724R and 727R). All animals
were maintained under uniform housing conditions and
nutritional regimens at the UCD Lyons Research Farm
(Newcastle, County Kildare, Ireland). The animals were
sourced from a herd managed by the UCD Lyons Research
Farm without a recent history of Johne’s disease. These
cattle were also negative for infection with Brucella
abortus, M. bovis (as confirmed by single intradermal
tuberculin test), Salmonella Typhimurium, bovine her-
pesvirus 1 (BHV-1) and bovine viral diarrhoea (BVD)
virus.
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For monocyte isolation, 300 mL of whole blood was col-
lected in acid citrate dextrose buffer (Sigma-Aldrich Ireland
Ltd., Dublin, Ireland) in sterile bottles. Blood was layered
onto AccuspinTM tubes containing HistopaqueW 1077
(Sigma-Aldrich Ireland Ltd., Dublin, Ireland) and following
density gradient centrifugation, peripheral blood mono-
nuclear cells (PBMC) were collected. Contaminating red
blood cells (RBC) were removed following resuspension
and subsequent incubation of the PBMC in RBC lysis buffer
(10 mM KHCO3, 150 mM NH4Cl, 0.1 mM EDTA pH 8.0)
for 5 min at room temperature. After incubation, PBMC
were washed twice with sterile phosphate-buffered saline
(PBS; InvitrogenTM, Life Technologies Corporation, Paisley,
UK) before resuspending cells in PBS containing 1% bo-
vine serum albumin (BSA; Sigma-Aldrich Ireland Ltd.,
Dublin, Ireland). Monocytes were then isolated using the
MACSW protocol involving magnetically-charged MACSW
MicroBeads conjugated to mouse anti-human CD14 anti-
bodies (Miltenyi Biotec Ltd., Surrey, UK), which has been
shown to be cross-reactive with bovine monocytes [26].
The MACSW protocol involves the incubation of cells with
antibody-conjugated MACSW MicroBeads that target cell-
specific antigenic markers (the monocyte CD14 cell sur-
face marker was targeted by the MACSW protocol used in
the current study). The sample-MicroBead mixture is then
applied to a MACSW column placed in a magnetic MACSW
separator. Cells lacking the CD14 marker pass through the
column while the magnetically-labelled cells carrying the
CD14 marker are retained within the column. The column
is washed, removed from the separator and the CD14-
carrying monocytes are subsequently eluted from the
column and used for MDM purification and culture. All
MACSW procedures were carried out according to the ma-
nufacturers’ instructions.
The identity and purity of monocytes was confirmed by
flow cytometry using an anti-CD14 fluorescein-labelled
antibody (data not shown). This method has been previ-
ously shown by us to yield a purity of CD14+ cells ≥ 99%
[27]. Purified monocytes were seeded at 1 × 106/well in
24-well tissue culture plates using RPMI 1640 medium
(InvitrogenTM, Life Technologies Corporation, Paisley,
UK) containing 15% heat inactivated foetal calf serum
(FCS; Sigma-Aldrich Ireland Ltd., Dublin, Ireland), 1%
non-essential amino acids (NEAA; Sigma-Aldrich Ireland
Ltd., Dublin, Ireland) and gentamicin (50 μg/mL; Sigma-
Aldrich Ireland Ltd., Dublin, Ireland) and incubated at 37°
C, 5% CO2. Following 24 hours incubation (day one) the
media was replaced with 1 mL fresh antibiotic-containing
media to remove any non-adhered cells. On day three,
media was replaced with 1 mL antibiotic-free culture
media (RPMI 1640 medium containing 15% heat inacti-
vated FCS and 1% NEAA only). To ensure that the same
number of MDM were subjected to different treatmentsbetween experiments, cells were dissociated on day five
using 1× non-enzymatic cell dissociation solution (Sigma-
Aldrich Ireland Ltd., Dublin, Ireland), counted and then
re-seeded at 2 × 105 cells/well in fresh 24-well tissue cul-
ture plates (Sarstedt Ltd., County Wexford, Ireland) using
antibiotic-free culture media (RPMI 1640 medium con-
taining 15% heat inactivated FCS and 1% NEAA). By day
eight, 80-100% confluent monolayers of MDM were
generated that displayed the characteristic macrophage
morphology as confirmed by Giemsa staining (data not
shown). Day eight MDM were used for the in vitro infec-
tion experiments withM. avium subsp. paratuberculosis.
Culture of M. avium subsp. paratuberculosis
A single clinical isolate of M. avium subsp. paratuberculo-
sis was provided by Mr Eamon Costello and Mr Kevin
Kenny (the Irish Central Veterinary Research Laboratory,
Backweston, County Kildare). The clinical isolate of M.
avium subsp. paratuberculosis used was obtained from a
field-infected animal sourced from a herd with confirmed
Johne’s disease. This isolate was prepared on Herrold's Egg
Yolk Agar supplemented with amphotericin, nalidixic acid,
vancomycin, with mycobactin J (Becton, Dickinson Ltd.,
Oxford, UK). Colonies from the agar preparations were
resuspended in sterile PBS, aliquoted (0.5 mL) and stored
at -80°C until required for in vitro MDM infections. Prep-
aration of M. avium subsp. paratuberculosis aliquots was
performed in a Biosafety Containment Level 3 (CL3)
laboratory and conformed to the national guidelines on
the use of Hazard Group 3 infectious organisms. It is im-
portant to note however, that culturing ofM. avium subsp.
paratuberculosis may be performed in a CL2 laboratory.
In vitro infection of bovine MDM with M. avium subsp.
paratuberculosis
A schematic outlining the experimental design used in
the current study is depicted in Figure 1. All infection
experiments, including the preparation of non-infected
control MDM, were performed in the CL3 laboratory
(note: experimental infections involving M. avium subsp.
paratuberculosis may be performed in a CL2 laboratory)
[28]. Prior to the MDM infection experiments, MDM
from two adjacent culture plate wells were lysed using
RLT buffer from the RNeasy Mini kit (Qiagen Ltd.,
Crawley, UK) supplemented with 1% β-mercaptoethanol
(Sigma-Aldrich Ireland Ltd., Dublin, Ireland) and pooled.
These samples constituted the 0 h non-infected control
MDM samples.
M. avium subsp. paratuberculosis aliquots (0.5 mL)
were removed from −80°C storage and thawed for
30 min at room temperature prior to infection, placed
in 9.5 mL RPMI 1640 medium (containing 15% heat
inactivated FCS and 1% NEAA only), sterile filtered
using a 5 micron filter (Millipore Ireland Ltd., County
Figure 1 Schematic depicting the experimental design used in the current study. MDM were cultured in 24-well tissue culture plates and
infected with M. avium subsp. paratuberculosis (MOI 2:1). RNA was extracted from infected (MPTb) and non-infected control MDM at three time
points post-infection: 2 h, 6 h and 24 h. In addition, RNA was extracted from 0 h non-infected control MDM to assess potential non-experimental
changes in gene expression. The MDM lysates from replicate tissue culture wells (shaded) were pooled for RNA extraction. Global gene expression
for the non-infected control and infected MDM was analysed using the AffymetrixW GeneChipW Bovine Genome Array.
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was confirmed by microscopy) and incubated at room
temperature for 1 h before being counted using Petroff
Hausser chamber (Fisher Scientific Ltd., Dublin, Ireland).
MDM (seeded at 2×105 cells/well) were infected with M.
avium subsp. paratuberculosis (4 ×105 cells/well) (multipli-
city of infection 2:1) and incubated at 37°C, 5% CO2 for 2 h,
6 h and 24 h. For the non-infected control MDM samples
at each time-point, antibiotic-free culture media (RPMI
1640 medium containing 15% heat inactivated FCS and 1%
NEAA only) was added to each well. After 2 hpi, the media
from all 6 h and 24 h infection experiments was replaced
with 0.5 mL fresh antibiotic-free culture media per well and
re-incubated at 37°C, 5% CO2 until MDM were required
for harvesting. Infected and non-infected control MDM
were lysed and harvested using RLT-1% β-mercaptoethanol
buffer (Qiagen Ltd., Crawley, UK) at the designated time
points. For each non-infected control and infected sample,
MDM lysates from two culture plate wells were pooled and
stored at -80°C until required for RNA extraction.
For colony-forming unit (cfu) counts, the M. avium
subsp. paratuberculosis preparation used for the MDM
infections was cultured using Middlebrook 7H11
medium (DifcoTM, Becton, Dickinson Ltd., Oxford, UK)
containing 0.50% (volume per volume) glycerol, 10%
(volume/volume) Middlebrook (OADC) growth supple-
ment (Becton, Dickinson Ltd., Oxford, UK) and 1 μgmycobactin J (Allied Monitor Inc., Fayette, MO, USA).
Cfu counts yielded a mean MOI of 2:1.
RNA extraction and microarray analysis
RNA was extracted using an RNeasy kit incorporating an
on-column DNase treatment step (Qiagen Ltd., Crawley,
UK) according to the manufacturer’s instructions. RNA
quantity and quality was assessed using a NanoDropTM
1000 spectrophotometer (Thermo Fisher Scientific,
Waltham, MA, USA) and an Agilent 2100 Bioanalyzer with
an RNA 6000 Nano LabChip kit (Agilent Technologies
Ltd., Cork, Ireland). All samples displayed a 260/280 ratio
greater than 2.0 and RNA integrity numbers (RIN) greater
than 8.5.
cDNA labelling, hybridisation and scanning for the
microarray experiments were performed by Almac
Diagnostics Ltd. (Craigavon, Co. Armagh, Northern Ire-
land) using a one-cycle amplification/labelling protocol
on the Affymetrix GeneChipW Bovine Genome Array
[29]. This array contains 24 072 probe sets representing
over 23 000 gene transcripts and includes approximately
19 000 UniGene clusters. Technical replicates were not
performed in this study. The procedures used for cDNA
labelling, hybridisation and scanning for the microarray
experiments are provided in the Additional Information.
In total, 49 microarrays were prepared in the current
study. These were generated from total RNA isolated
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non-infected control MDM, seven 2 h infected MDM,
seven 6 h non-infected control MDM, seven 6 h infected
MDM, seven 24 h non-infected control MDM and seven
24 h infected MDM.Statistical analysis of microarray data
AffymetrixW GeneChipW Bovine Genome Array data
were analysed using the Bioconductor software project
[30] contained within the R statistical environment [31].
Microarray quality control was performed using the
Simpleaffy package contained within Bioconductor [32].
Normalisation of raw data was performed using the Fac-
tor Analysis for Robust Microarray Summarization
(FARMS) algorithm within Bioconductor. The FARMS
algorithm uses only perfect match probes and a quantile
normalization procedure, providing both P-values and
signal intensities [33]. Normalised data were then fur-
ther subjected to filtering for informative probes sets
using the Informative/Non-informative calls (I/NI-calls)
[34] software package in R. This software package uses
multiple probes for the same gene as repeated measures
to quantify the signal-to-noise ratio of that specific
probe set.
Differentially expressed genes were extracted using the
Linear Models for Microarray Data (LIMMA) package [35]
contained within Bioconductor. Genes displaying differen-
tial expression patterns between non-infected control and
infected MDM were annotated using the AffymetrixW
bovine gene annotation [36]. The Benjamini-Hochberg
multiple testing correction method [37] was applied to all
differentially expressed genes to minimise the false dis-
covery rate (FDR) and adjusted P-values for differen-
tially expressed genes were calculated. In this study,
an adjusted P-value threshold of ≤ 0.10 was chosen.
Geometric mean fold-changes in gene expression are pre-
sented in the current study following back-transformation
of mean log2 fold-changes obtained from statistical ana-
lysis of microarray data. For replicate probes for sin-
gle genes, the average log2 expression fold-change
was used and subsequently back-transformed. The
negative reciprocals of the geometric fold-changes
were calculated and are presented for downregulated
genes.
All data are MIAME compliant [38] and have been
submitted to the NCBI Gene Expression Omnibus
(GEO) database [39] with experiment series accession
numbers GSE35185. It is important to note that one
microarray (6 h infected MDM RNA sample; animal
number 713) failed quality control based on the analysis
performed using the Simpleaffy package. This sample
was omitted from the statistical analysis of the micro-
array data.Systems biology analyses
IngenuityW Systems Pathway Analysis (IPA; Ingenuity
Systems, Redwood City, CA, USA) was used to identify ca-
nonical pathways and functional processes of biological im-
portance within the list of differentially expressed genes.
The IngenuityW Knowledge Base contains the largest data-
base of manually-curated and experimentally-validated
physical, transcriptional and enzymatic molecular interac-
tions. Furthermore, each interaction in the IngenuityW
Knowledge Base is supported by previously published
information.
For IPA analysis, the AffymetrixW GeneChipW Bovine
Genome Array was used as a reference gene set. All dif-
ferentially expressed genes with an adjusted P value ≤
0.10 were included. For replicate probe IDs, the mean
log2 expression fold-change was used. Only differentially
expressed genes mapping to molecules in the IngenuityW
Knowledge Base were used for systems analysis. Func-
tional analysis of genes was performed using IPA to
characterise the biological functions of the differentially
expressed genes between the non-infected control and
infected MDM. For this, IPA performed an over-repre-
sentation analysis that categorises the differentially
expressed genes within the uploaded list into functional
gene ontology (GO) categories using the IngenuityW
Knowledge Base. Each GO category in IPA is ranked
based on the number of differentially expressed genes
falling into each functional group. Right-tailed Fisher’s
exact tests were used to calculate a P-value for each of
the biological function assigned to list of differentially
expressed genes.
IPA contains a large library of known canonical path-
ways that were overlaid with the differentially expressed
genes to identify major biological pathways associated
with M. avium subsp. paratuberculosis infection in
MDM in vitro. The significance of the association be-
tween differentially expressed genes and the canonical
pathway was assessed using two methods: (1) a ratio of
the number of molecules from the differentially
expressed gene data set that map to the pathway com-
pared to the total number of molecules that map to the
canonical pathway based on the reference gene list; and
(2) a Fisher’s exact test that generates a P-value for the
assignment of the differentially expressed genes to a par-
ticular canonical pathway compared to the reference
gene list. Canonical pathways were then overlaid with
the expression values of the differentially expressed
genes.
Conventional cDNA preparation for real time quantitative
reverse transcription PCR (qRT-PCR) analysis
cDNA was prepared from 80 ng of total RNA (including
the 0 h non-infected control RNA samples) using a High
Capacity cDNA Reverse Transcription Kit (Applied
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UK) from all 49 RNA samples used in the microarray hybri-
disations. cDNA conversions were performed in 20 μL reac-
tions using random primers as per the manufacturer’s
instructions. In addition, 80 ng of pooled RNA (~10 RNA
samples per pool) was included in non-reverse transcriptase
(non-RT) control reactions to test for the presence of con-
taminating genomic DNA during real-time qRT-PCR ana-
lysis. All cDNA samples and non-RT controls were diluted
1:8 using RNAse- and DNAse-free water (yielding a final
cDNA concentration of 0.5 ng/μL) and stored at −20°C
prior to real time qRT-PCR analysis.
Whole-transcriptome amplified cDNA preparation for real
time quantitative reverse transcription PCR (qRT-PCR)
analysis
To generate a repository of cDNA from each RNA sample,
whole-transcriptome linearly amplified cDNA was prepared
using the WT-OvationTM RNA Amplification System
(NuGEN Technologies Inc., Bemmel, The Netherlands).
For this, 25 ng of template RNA from all 49 RNA samples
was included in each amplification reaction and all proce-
dures were performed according to the manufacturer’s
instructions. In addition, non-template controls that
included RNAse- and DNAse-free water instead of RNA
template were also prepared using the WT-OvationTM
RNA Amplification System kit. Once amplification reac-
tions were completed, the amplified cDNA and non-
template controls were diluted 1:1000 using RNAse- and
DNAse-free water and stored at −20°C prior to real time
qRT-PCR analysis.
Real time quantitative reverse transcription PCR (qRT-PCR)
analysis and validation of microarray results
Intron-spanning primers were designed for each gene using
the Primer3Plus package [40] and commercially synthesised
(Eurofins MWG Operon, Ebersberg, Germany). Additional
file 1: Table S1 provides experimental information for all
primer pairs used. Real time qRT-PCR reactions (20 μL final
volume) were performed on 96-well plates using Fast
SYBRW Green Master mix (Applied BiosystemsTM, Life
Technologies Ltd., Warrington, UK) on a 7500 Fast Real-
Time PCR System (Applied BiosystemsTM, Life Technolo-
gies Corporation, Warrington, UK) as per manufacturer’s
instructions. Real time qRT-PCR amplifications contained
either: (a) 2 μL of the diluted conventionally-prepared
cDNA/non-RT control (equivalent to 1.0 ng of total RNA
template); or (b) 2 μL of the diluted linearly amplified
cDNA/non-RNA template control. A final concentration
of 300 nM of each forward and reverse primer was
included in each amplification reaction. Non-template real
time qRT-PCR controls, non-RT controls and a seven-
point standard curve prepared from 1:2 serial dilutions of
pooled conventionally-prepared cDNA or linearly amplifiedcDNA from each infected and non-infected control MDM
sample were included on every real time qRT-PCR plate.
PCR thermal cycling conditions for each amplicon
comprised one cycle at 50°C for 2 min, one cycle at 95°C
for 20 s, followed by 40 cycles at 95°C for 3 s and 60°C
for 30 s. A dissociation step was included for all amplifi-
cations to confirm the presence of single discrete PCR
products of the expected size; this was further confirmed
by visualisation of the amplification products on 2%
agarose gels stained with 0.5 μg/mL ethidium bromide
(InvitrogenTM, Life Technologies Corporation, Paisley,
UK).
Statistical analysis of real time qRT-PCR data
All real time qRT-PCR data, including estimation of pri-
mer efficiencies estimations using the standard curves,
were analysed using the qbasePLUS software package [41].
Real time qRT-PCR efficiency correction and normalisa-
tion was performed using the peptidylprolyl isomerase A
(cyclophilin A) gene (PPIA) based on GeNorm analysis
performed by us in a previous study involving bovine
MDM [27]. PPIA expression profiles were generated for
both the conventionally-prepared and linearly amplified
cDNA templates for all samples to ensure appropriate
real time qRT-PCR efficiency correction and normalisa-
tion analyses were performed for all genes-of-interest.
Calibrated normalised relative quantities (CNRQ) of
gene expression for each analysed sample as generated
by the qbasePLUS package were used to calculate fold-
changes in expression for each gene. For this, the CNRQ
value generated for each infected MDM sample was
divided by the CNRQ value generated for the non-
infected control MDM sample at the corresponding
post-infection time point from the same animal. Log2
fold-changes in gene expression were then used for the
statistical analysis of all genes analysed using real time
qRT-PCR. All statistical analyses were performed using
the SPSS version 18 (IBM Corporation, Armonk, NY,
USA) and Minitab version 16 (Minitab Ltd., Coventry,
UK) statistical packages.
Anderson-Darling tests of normality were applied to
the residuals of the log2 fold-change values at each time
point prior to statistical analysis to ensure the data con-
formed to a normal distribution–no significant depar-
tures from normality were observed for any of the genes
analysed (P ≥ 0.05). Two-tailed paired Student’s t-tests
were used to assess significant differences in mean log2
fold-changes in gene expression between the infected
MDM and the non-infected control MDM at each time
point post-infection. Geometric mean fold-changes in ex-
pression were generated and are presented for each gene
by back-transformation of the log2 fold-change data. The
negative reciprocals of the geometric fold-changes were
calculated and are presented for downregulated genes.
Figure 2 The number of significantly differentially expressed genes at each time point post-infection with M. avium subsp.
paratuberculosis. The number of upregulated and downregulated genes in the infected MDM relative to the non-infected control MDM at each
time point are shown (adjusted P-value ≤ 0.10).
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cDNA in real time qRT-PCR amplifications and to en-
sure that no over- or under-representation of mRNA
transcripts was introduced into the samples following
amplification, the expression profiles of three genes
(CCL5, CCL20 and IL1B) were generated using both con-
ventionally prepared cDNA and linearly amplified cDNA.
The log2 fold-changes in expression in the infected
MDM relative to the non-infected control MDM at each
time point were then compared for both template types
using regression analysis.
Results
Analysis of gene expression 2 hpi
A total of 1232 transcripts, representing 1050 unique
genes, were identified as being differentially expressed
between the infected and non-infected control MDM
samples 2 hpi (adjusted P-value ≤ 0.10). Of these, 673
transcripts (representing 547 unique genes) were upregu-
lated with the remaining 559 transcripts (representing
503 unique genes) displaying downregulation in the
infected MDM (Figure 2). In addition, the relative fold-
change in expression was markedly higher for the upre-
gulated genes compared to the downregulated genes at
this time point. A complete list of the differentially
expressed genes and the relative fold-change in expres-
sion at the 2 h time point post-infection are provided in
Additional file 2: Table S2.
Further inspection of the differentially expressed genes
revealed that many of the highly upregulated genes at
this time point had immune-related functions, particu-
larly NF-κB-inducible chemokine and cytokine genes,
such as the chemokine (C-X-C motif ) ligand 2 gene
(CXCL2); the interleukin 1, beta gene (IL1B); the inter-
leukin 1, alpha gene (IL1A); the tumour necrosis factorgene (TNF); the chemokine (C-C motif ) ligand 20 gene
(CCL20) and the interleukin 6 and interleukin 10 genes
(IL6 and IL10). The gene encoding nitric oxide synthase
2 (NOS2), whose function is to produce reactive nitric
oxide-a potent effector molecule involved in the regula-
tion of the host immune response to mycobacterial
infection [42]-was also upregulated 2 hpi. Finally, the
genes encoding the NF-κB1 (NFKB1) and NF-κB2
(NFKB2) members of the NF-κB transcription factor
complex were upregulated in the infected MDM at this
time encoding proteins belonging to the mitogen-
activated protein kinase (MAPK) signalling cascade-
which is involved in the activation of downstream
cellular responses upon the recognition of mycobacterial
pathogen-associated molecular patterns (PAMPs) by cell
surface pathogen recognition receptors (PRRs), such as the
Toll-like receptors (TLRs) and the receptor tyrosine
kinases (RTKs) [15]-were also differentially expressed at
this time point. These included members of the mitogen-
activated protein kinase kinase kinases (MAPKKKs), the
mitogen-activated protein kinase kinases (MAPKKs) and
the mitogen-activated protein kinases (MAPKs). Notably,
genes encoding MAPK-activated transcription factors,
such as the JUN proto-oncogene (JUN) and the FBJ
murine osteosarcoma viral oncogene homolog gene (FOS),
displayed the greatest reduction in fold-change expression
in the infected samples.
The total number of differentially expressed genes 2
hpi that could be mapped to molecules in the IngenuityW
Knowledge Base was 841 from a total of 1232 differen-
tially expressed transcripts. Functional categorisation
analysis using IPA showed that the differentially
expressed genes 2 hpi had roles involved in the regula-
tion of gene transcription, the immune response, cell sig-
nalling, and cell death (Additional file 3: Table S3). IPA
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ways enriched for differentially expressed genes in re-
sponse to M. avium subsp. paratuberculosis infection.
Many of the top ten ranking canonical pathways identi-
fied had an immunological role and included Interleukin
10 signalling (1st ranked pathway), Dendritic cell matur-
ation (2nd ranked pathway), TNFR2 signalling (3rd ranked
pathway), The role of macrophages in rheumatoid arth-
ritis (4th ranked pathway) and B cell activating factor
signalling (5th ranked pathway) (Additional file 4: Table
S4).
Analysis of gene expression 6 hpi
Comparison of the microarray expression profiles of the
infected MDM and non-infected control MDM 6 hpi
revealed a total of 1137 differentially expressed transcripts,
representing 974 unique genes (adjusted P-value≤0.10). Of
these, 713 transcripts (representing 590 unique genes) were
upregulated with the remaining 424 transcripts (represent-
ing 384 unique genes) displaying downregulation in the
infected MDM relative to the non-infected control MDM
(Figure 2). As with the data from the 2 hpi time point, the
relative fold-change in expression was markedly higher for
the upregulated genes compared to the downregulated
genes at this time point. A complete list of the differentially
expressed genes and the relative fold-change in expression
at the 6 hour time point post-infection are provided in
Additional file 5: Table S5.
Immune-related genes were among the differentially
expressed genes showing the highest relative increase in
expression; however, the fold-change induction of these
genes was not as high as those detected at the 2 h time
point. These genes included the chemokine (C-C motif )
ligand 4, 5 and 20 genes (CCL4, CCL5 and CCL20); the
CD40 molecule, TNF receptor superfamily member 5
gene (CD40), and the complement factor B gene (CFB).
CXCL2, IL1B, NFKB1, NFKB2, NOS2 and TNF were also
upregulated at this time point. IL10 was not differentially
expressed at this time point, while the genes belonging
to the MAPK signalling pathway that were identified as
being differentially expressed at the 2 hpi time point
were not differentially expressed at 6 hpi.
The total number of differentially expressed genes that
could be mapped to molecules in the IngenuityW
Knowledge Base 6 hpi was 768 from a total of 1137 differ-
entially expressed transcripts. Functional categorisation of
the differentially expressed genes 6 hpi revealed enrich-
ment for genes involved in the regulation of cellular deve-
lopment, inflammation, adaptive immune mechanisms and
cell death (Additional file 6: Table S6). The top ranking
IPA-identified canonical pathways enriched for differentially
expressed genes in response to M. avium subsp. paratuber-
culosis infection are detailed in Additional file 7: Table S7.
Among the top five ranking canonical pathways had an im-munological role and included TREM1 signalling (1st
ranked pathway); B cell receptor signalling (2nd ranked
pathway); Altered T cell and B cell signalling in rheumatoid
arthritis (3rd ranked pathway); and Communication between
innate and adaptive immune cells (5th ranked pathway).
Notably, inspection of the differentially expressed
genes within the 4th ranked canonical pathway, the role
of pattern recognition receptors in the recognition of
bacteria and viruses, showed that the genes encoding
TLR3 and the interferon induced with helicase C domain
1 (IFIH1) proteins were upregulated following infection.
This is of note, as TLR3 and IFIH1 are intracellular PRRs
largely involved in the recognition of viral PAMPs, such
as double-stranded reoviral RNA.Analysis of gene expression 24 hpi
A total of 86 transcripts, representing 78 unique genes,
were identified as being differentially expressed between
the infected and non-infected control MDM 24 hpi
(adjusted P-value ≤ 0.10). Of these, 72 transcripts (repre-
senting 64 unique genes) were upregulated with the
remaining 14 transcripts (representing 14 unique genes)
displaying downregulation in the M. avium subsp.
paratuberculosis-infected MDM (Figure 2). As with the
2 h and 6 h time points post-infection, the relative fold-
change in expression was higher for the upregulated
genes compared to the downregulated genes at this time
point. However, the fold-change in expression for the
upregulated genes at the 24 h time point was substan-
tially lower than that for the upregulated genes at the
earlier time points. A complete list of the differentially
expressed genes and the relative fold-change in expres-
sion at the 24 h time point post-infection are provided in
Additional file 8: Table S8.
Several of the differentially expressed genes identified
at the 24 hpi time point had no obvious immunological
role. Of the differentially expressed genes that had a
known immune function were the serum amyloid A3
gene (SAA3); the complement factor B gene (CFB); a
small number of members of the C-type lectin/C-type
lectin-like domain protein superfamily, such as the
genes encoding the C-type lectin domain family 4,
member E (CLEC4E) and C-type lectin domain family 2,
member D proteins (CLEC2D); and CD40-all of these
genes were upregulated at this time point. Although we
analysed the list of 78 differentially expressed genes
using IPA (59 differentially expressed genes from 86 dif-
ferentially expressed transcripts mapped to molecules in
IPA at this time point), these proved largely uninforma-
tive given the low number of differentially expressed
genes represented within each functional category and
canonical pathway (Additional file 9: Tables S9 and
Additional file 10: S10).
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analysis and validation of microarray results
A panel of the 15 genes identified through analysis of the
microarray data and previous in vitro mycobacterial in-
fection studies conducted in our laboratory [43] were
selected for real time qRT-PCR analysis and microarray
validation. Selection of these genes was based largely on
the highest fold increase or decrease in gene expression
following infection with M. avium subsp. paratuberculo-
sis and/or lowest adjusted P-value, using data primarily
from the 2 h and 6 h time points; however, gene selec-
tion also included information from the 24 h time point
where possible. The genes selected for real time qRT-
PCR analysis were: AREGB, CCL4, CCL5, CCL20, CD40,
CFB, CXCL2, IL1B, IL6, IL15, IRF1, NFKB2, PIK3IP1,
SPRY2 and TNF. cDNA prepared from all 49 RNA sam-
ples were included for real time qRT-PCR analysis.
Of the 15 genes analysed using real time qRT-PCR,
nine genes (CCL4, CD40, CFB, CXCL2, IL6, IL15, IRF1,
NFKB2 and TNF) were analysed using conventionally-
prepared cDNA template only; three genes (CCL5,
CCL20 and IL1B) were analysed using both the conven-
tionally-prepared cDNA and the linearly amplified cDNA
templates in order to validate the performance of the
linearly amplified cDNA; while the remaining three
genes (AREGB, PIK3IP1 and SPRY) were analysed using
the linearly amplified cDNA template only.
Firstly, to validate the performance of the linearly amp-
lified cDNA in real time qRT-PCR amplifications, the ex-
pression profiles generated for the CCL5, CCL20 and
IL1B genes using conventionally-prepared and linearly
amplified cDNA were compared. For this, regression
analysis was performed using the log2 fold-changes in
relative gene expression for the infected MDM analysed
for the two different cDNA templates across all three
time points, revealing a high correlation for all three
genes (r2 ≥ 0.82, P ≤ 0.001) (Figure S1). Furthermore, the
mean-fold changes in expression (and their associated
P-values) in the infected MDM relative to the non-
infected control MDM for these genes were similar
across all three time points (Additional file 12: Figure S1
and Additional file 11: Table S11). Only IL1B was shown
to be significantly differentially expressed at 24 hpi using
the conventionally prepared cDNA, while this gene was
not differentially expressed at this time point based on
data from the linearly amplified cDNA. These results
suggest that no significant preferential amplification bias
of gene transcripts or amplification artefacts occurred
during the preparation of the linearly amplified cDNA.
Consequently, we concluded that the use of the linearly
amplified cDNA was suitable in the current study.
The relative fold-changes in expression between the
infected and non-infected control MDM at each time
point post-infection for the CD40, IL1B, IL6 and TNFgenes as determined through real time qRT-PCR ana-
lysis are depicted graphically in Figure 3, while data for
all other genes analysed through real time qRT-PCR are
presented in Additional file 13: Figure S2. Mean fold-
changes in gene expression are presented in Table 1, as
are descriptions of the function of each gene, which
were obtained from the Entrez Gene [44] and the Gene-
Cards version 3 databases [45]. Fourteen of the 15 genes
analysed using real time qRT-PCR were significantly dif-
ferentially expressed at the 2 h time point, while 13 and
seven genes were significantly differentially expressed at
the 6 h and 24 h time points, respectively (P ≤ 0.05). In
total, six genes (CCL5, CD40, CFB, IL1B, IRF1 and
TNF) were significant upregulated across all three time
points (P ≤ 0.05), while only one gene (AREGB) was sig-
nificantly downregulated in the infected MDM samples
across all time points (P ≤ 0.05). Furthermore, compari-
son of the expression profiles of each gene for the 2 h,
6 h and 24 h non-infected control MDM relative to the
0 h non-infected control MDM revealed significant dif-
ferentially expression for only the AREGB gene at the
2 h and 6 h time points (P ≤ 0.01). The expression pro-
files of the 2, 6 and 24 h non-infected control MDM for the
remaining 14 genes were not significantly different relative
to the 0 h non-infected control MDM (P ≥ 0.05).
Comparisons between the results from the real time
qRT-PCR and microarray analyses for all 15 genes are
given in Table 1. In general, gene expression profiles for
all 15 genes analysed with real time qRT-PCR were the
same as those detected based on microarray analysis
across all three time points. The expression profiles of
AREGB and SPRY2 at the 2 h time point, IL6 at the 6 h
time point and AREGB, CCL5, IL1B, IRF1 and TNF at
the 24 h point were different between the two datasets. Of
the total 45 pairwise comparisons between the microarray
data and the real time qRT-PCR data (i.e. 15 genes×3 time
points), eight were discordant, giving a concordance rate
between the two datasets of 82% (i.e. 37/45).
The observed discrepancies between the microarray and
real time qRT-PCR data for these genes may reflect differ-
ences in the sensitivity of the two analytical methods used
and/or differences in the mRNA transcripts targeted by the
probes (microarray) and primer pairs (real time qRT-PCR)
used for the two forms of gene expression analysis [46]. In
addition, the differences between the two datasets may re-
flect the application of the Benjamini-Hochberg multiple
testing correction method [37] to all differentially expressed
genes identified through the analysis of the microarray data
(adjusted P-value threshold ≤ 0.10). This statistical correc-
tion was not applied to the real time qRT-PCR as the genes
selected for this analysis were based on: (1) the list of differ-
entially expressed genes identified from the microarray data
presented in the current study, and (2) data generated by us
from previous studies investigating the bovine immune
Figure 3 Real time qRT-PCR analysis of the CD40, IL1B, IL6 and TNF genes following infection with M. avium subsp. paratuberculosis.
Log2 fold-changes in expression in the M. avium subsp. paratuberculosis-infected MDM (MPTb) relative to the non-infected control MDM at all
three time points are shown. All data presented is based on the conventionally-prepared cDNA template. For comparison, the expression profiles
for these genes as per the microarray data are also shown. The significance of the fold-changes in expression for each gene based on the real
time qRT-PCR analysis only are denoted by asterisks in the figure (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001). In addition, the log2 fold-change in
expression for the non-infected control MDM at each time point relative to the 0 hour non-infected control MDM are also shown for both the
microarray and real time qRT-PCR data; no significant differences in gene expression between the non-infected control MDM relative to the 0 h
non-infected control was observed at each time point (P ≥ 0.05).
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[43]. Therefore, analysis of the real time qRT-PCR analysis
data generated in the current study was based on a priori
knowledge and was not subject to the same rigorous post-
hoc statistical correction as the microarray data [47-49].
Discussion
High-throughput transcriptomic technologies, coupled
with continually improving genome resources, have
greatly enhanced the ability to interrogate global changesin gene expression underlying the cellular response to
mycobacterial infection [23,24,50-53]. More specifically,
these studies have enabled a deeper knowledge of the
complex interactions between host mammalian macro-
phages and mycobacterial pathogens in vitro, thus, pro-
viding a model for understanding the molecular basis of
mycobacterial disease. However, most of this research
has focussed on the host transcriptional response to M.
tuberculosis and M. bovis infection in humans and cattle,
respectively, with a paucity of studies centred on the host
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AREGB Amphiregulin B A growth-modulating
glycoprotein




































+ 4.44 + 6.55 ≤ 0.001 + 5.23 + 10.80 ≤ 0.001 + 1.71 + 1.82 ≤ 0.05
CFB Complement
factor B
A component of the
alternative pathway of
complement activation









+ 14.34 + 28.56 ≤ 0.001 + 2.38 + 3.07 ≤ 0.01 NS + 1.45 NS
IL1B Interleukin 1,
beta
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Table 1 Comparison of fold-changes in gene expression in the infected MDM relative to the non-infected control MDM based on microarray and real time qRT-
PCR results (Continued)
IL15 Interleukin 15 A cytokine that
regulates T and natural
killer cell activation
and proliferation

























































+ 13.89 + 33.01 ≤ 0.001 + 2.73 + 6.51 ≤ 0.01 NS + 1.61 ≤ 0.01
Geometric mean fold-changes of gene expression (infected MDM relative to non-infected control MDM from the same animal at each time point) are given for the microarray and real time qRT-PCR data at each time
point. “NS” indicates that the gene was not significantly differentially expressed at the appropriate time point. The P-values obtained from analysis of the real time qRT-PCR analysis are presented. Geometric fold-
changes given for the microarray data were significantly differentially expressed using an adjusted P-value ≤ 0.10. Descriptions of the function of each gene were obtained from the Entrez Gene database [44] and the
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infection. Consequently, we have investigated transcrip-
tional changes in bovine MDM isolated from seven
Holstein-Friesian females in response to M. avium subsp.
paratuberculosis infection in vitro using the genome-wide
high-density AffymetrixW GeneChipW Bovine Genome
Array at 2, 6 and 24 hpi. The gene expression data from
these analyses were used to investigate key host macrophage
signalling pathways involved during early M. avium subsp.
paratuberculosis infection.
Comparison of the gene expression profiles in the
infected MDM relative to the non-infected control
MDM at each time point revealed a sequential decrease
in the number of differentially expressed genes across
the three time points analysed. In particular, there was a
dramatic reduction in the number of differentially
expressed genes at the 24 h time point (n= 78) compared
to the number of differentially expressed genes detected
at the 2 h (n= 1050) and 6 h (n= 974) time points, re-
spectively. These results indicate that the majority of
transcriptional changes occur within the first 6 hpi, with
differential gene expression having largely abated at the
24 h time point. In addition, the number of upregulated
genes exceeded the number of downregulated genes at
each time point (547 upregulated/503 downregulated at
2 h; 590 upregulated/384 downregulated at 6 h; 64 upre-
gulated/14 downregulated at 24 h), while the relative
fold-change in expression for the upregulated genes was
greater than that for the downregulated genes at each
time point. These results are similar to previous findings
demonstrating an over-representation of upregulated genes
in peripheral blood mononuclear cells (PBMC) isolated
from Johne’s disease-positive cattle following in vitro stimu-
lation with M. avium subsp. paratuberculosis, while the
number of differentially expressed genes also decreased dra-
matically across a 16 h post-stimulation time course [54].
Previous functional genomic studies have shown that
in vitro and in vivo models of tuberculosis infection are
associated with repression of host gene expression
[51,55-57]-a strategy that is proposed to enable myco-
bacterial persistence in the host [58,59]. Furthermore,
gene expression data generated from a recent in vitro M.
bovis-bovine MDM infection study performed by our
group (MOI 2:1) revealed that the number of differen-
tially expressed genes increased sequentially across 2, 6
and 24 h intervals post-infection [43]. In addition, the
number of downregulated genes in the M. bovis-infected
MDM exceeded the number of upregulated genes at
each time point, thus lending further support to the hy-
pothesis that M. bovis infection is association with tran-
scriptional repression [43].
The increased number of upregulated genes compared
with downregulated genes, coupled with the reduction in
the number of differentially expressed genes at each timepoint post-infection, as observed in the current study, sup-
ports previous work showing that M. avium subsp. paratu-
berculosis infection causes transient upregulation of host
gene expression [54,60]. Furthermore, differences in the
number and expression profiles (i.e. up- or downregulation)
of MDM genes expressed following M. avium subsp. para-
tuberculosis and M. bovis infection in vitro, as observed
here and by us previously [43], indicate that different
macrophage responses are elicited upon infection with
different mycobacterial species. These results may also
highlight different immuno-modulatory strategies used by
different mycobacterial pathogens to survive and prolife-
rate in host macrophages.
Inspection and systems analysis of the list of differen-
tially expressed genes identified following M. avium
subsp. paratuberculosis infection in the present study
enabled further understanding of the major cellular
mechanisms occurring at each time point post-infection.
For example, TLR2 was the only TLR-encoding gene
found to be differentially expressed (upregulated) in the
infected MDM at the 2 h time point; a result that sug-
gests that this PRR plays an important role in the early
macrophage recognition of M. avium subsp. paratuber-
culosis. This finding supports the conclusions of previous
studies which demonstrate that TLR2 expression is upre-
gulated in bovine monocytes following M. avium subsp.
paratuberculosis infection in vitro [61] and also in sub-
clinical and clinical forms of sheep paratuberculosis [62].
NF-κB-inducible cytokine and chemokine genes (such
as CCL20, CXCL2, IL1B, IL1A, IL6 and TNF), whose
expression profiles are known to be altered following
mycobacterial recognition by TLR2 [63,64], displayed the
highest fold-increase in relative expression following M.
avium subsp. paratuberculosis infection at the 2 h time
point. These findings confirm that endogenous macrophage
cytokine and chemokine gene expression is a key early
event during mycobacterial infection in vitro [27,50,65-67].
Notably, the gene encoding the TLR2 adaptor protein, mye-
loid differentiation primary response 88 (MYD88), and the
genes encoding other downstream TLR-signalling proteins,
such as the interleukin-1 receptor-associated kinases
(IRAKs), were not differentially expressed at this time point.
Thus, it is possible that M. avium subsp. paratuberculosis
infection activates TLR2-mediated signalling via a non-
canonical pathway involving less well-defined TLR signal-
ling pathway protein adaptors and intermediates [68].
However, as this is a transcriptomics study, the func-
tional role of various pre-existing TLR adaptor proteins
in macrophage cellular pathways during M. avium subsp.
paratuberculosis infection cannot be assessed at the RNA
level and consequently, their involvement in these path-
ways cannot be fully excluded. Further work involving
both transcriptomic and proteomic platforms is required
to investigate fully a role for macrophage non-canonical
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paratuberculosis infection.
Genes encoding members of the MAPK signalling cas-
cade were also differentially expressed at the 2 h time
point post-infection. The MAPK signalling cascade con-
sists of evolutionarily conserved serine/threonine kinases
that relay extracellular stimuli (often mediated through
activation of TLRs [69]) to transcription factors that
induce the expression of genes whose encoded products
regulate various cellular processes including the innate
immune responses. The MAPK signalling cascade is
comprised of a three-tiered kinase system in which
MAPKs-such as the p38 MAPK isoforms (p38α, β, γ and
δ), the c-JUN N-terminal kinases (JNK1, 2 and 3) and
the extracellular related kinases (MAPK-ERKs 1,2 and
3)-are activated through phosphorylation by MAPKKs
(also called MAP2K/MKK/MEK proteins), which are
activated through phosphorylation by MAPKKKs (also
called MAP3K/MEKK proteins). Upon activation,
MAPKs can translocate to the nucleus where they phos-
phorylate and activate several nuclear targets, including
the FOS, JUN, and SP1 transcription factors that regulate
the expression of genes encoding inflammatory chemo-
kine and cytokines, including IL-1, IL-10, IL-12 and
TNF-α [70,71].
In the current study, genes encoding members of the
three tiers of the MAPK signalling cascade were differen-
tially expressed in the infected MDM 2 hpi, some of
which displayed opposing expression profiles. For ex-
ample, MAP3K14 (also called NIK) was downregulated,
while MAP3K8 was upregulated; MAP2K3 and MAP2K4
were both upregulated; MAPK6 (also called ERK3) was
upregulated and MAPK14 (also called MAPK-p38α) was
downregulated at this time point. In addition, FOS and
JUN were downregulated at this time point post-
infection.
These data support results from previous studies
which demonstrate that MAPK signalling is modulated
upon infection, a mechanism that may enable mycobac-
terial persistence in host macrophages [58]. For ex-
ample, chemical inhibition of MAP2K1 (also called
MEK1) and MAPK-ERK activity resulted in reduced
TNF-α secretion and enhanced replication of patho-
genic M. avium in infected human MDM in vitro [72].
Furthermore, enhanced phosphorylation of MAPK14
has been shown to be primarily responsible for upregu-
lation of IL10, which encodes a key mediator of the
host innate immune response to mycobacterial infection
[73,74]. IL-10 is an immuno-regulatory cytokine pro-
duced by macrophages and other immune cells (such as
T and B lymphocytes) that suppresses anti-mycobacter-
ial activity-possibly by inhibiting NF-κB activity in target
cells [75]-thus, limiting the level of local cytokine-
induced tissue damage and systemic inflammatoryresponses during infection [76]. Interestingly, Weiss et al.
[61] demonstrated that inhibition of IL-10 production in
human monocytes following M. avium subsp. paratubercu-
losis infection in vitro result in enhanced phagosome matu-
ration and mycobactericidal mechanisms. These findings
have led to the proposal that mycobacteria modulate MAPK
signalling pathways-particularly by inducing increased phos-
phorylation of MAPK14-resulting in the upregulation of
IL10 causing subsequent suppression of host innate im-
mune responses to infection and enhanced mycobacterial
intracellular proliferation [15,77].
In the current study, IL10 was upregulated 2 hpi while
IL-10 signalling was the top ranking canonical pathway
identified at this time point. These results confirm the
important role of IL-10 during M. avium subsp. paratu-
berculosis infection and support the hypothesis that
mycobacteria exploit the anti-inflammatory activity of
this cytokine to promote intracellular survival. However,
the downregulation of MAPK14 suggest that the induc-
tion of IL10, as observed here, does not involve increased
MAPK14 expression; instead IL10 upregulation may be
due post-transcriptional modification of MAPK14 (e.g.
phosphorylation) not detected here or may be induced
through an alternative cellular signalling mechanism.
Previous investigations have highlighted the important
role of apoptosis in the host response to mycobacterial
infection. In particular, macrophage apoptosis is increasingly
regarded as host innate immune mechanism controlling
mycobacterial infection by containing and limiting myco-
bacterial growth [78]. In the current study, several pro- and
anti-apoptotic genes were differentially expressed at the 2
hour and 6 hour time points post-infection. These included
TNF (upregulated, pro-apoptotic), the caspase 1, 4 and 6
genes (CASP1, CASP4, CASP6; all upregulated, all pro-
apoptotic), the baculoviral IAP repeat containing 3 gene
(BIRC3; upregulated, anti-apoptotic) and the CASP8 and
FADD-like apoptosis regulator gene (CFLAR; upregulated,
the isoforms of the protein encoded by this gene can act as
either a pro- or anti-apoptotic mediators). Functional
categorisation also revealed enrichment for genes involved
in apoptosis at these two time points post-infection. The
expression profiles of these genes concur with results from
a recent study investigating the immuno-specific response
of bovine MDM following 6 hpi with M. avium subsp.
paratuberculosis [23].
While the upregulation of pro-apoptotic genes following
M. avium subsp. paratuberculosis infection supports the
induction of macrophage apoptosis, presumably to elimin-
ate the intracellular pathogen [79], the upregulation of
several anti-apoptotic genes suggests that this process is
highly regulated. Anti-apoptotic signals may represent a
host mechanism to limit the amount of host cell death
following infection and may also enable improved antigen
presentation by infected macrophages to T cells, leading
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tion in granulomas by adaptive immune mechanisms [80].
Alternatively, the induction of anti-apoptotic genes may
signify immuno-subversion mediated by the pathogen,
enabling survival and replication within the macrophage
and evasion of the host immune response [81]. It is also
possible that the pro- and anti-apoptotic signals detected
here represent transcriptional signatures of “bystander”
apoptosis, whereby uninfected macrophages undergo
apoptosis following contact with mycobacteria-infected
macrophages [23,82].
At the 6 hpi time point, there was a notable attenu-
ation in the fold-change upregulation of many of the
inflammatory cytokine genes (e.g. CCL20, CXCL2, IL1B
and TNF) in the infected MDM compared with their
fold-increase in expression at the 2 h time point. Fur-
thermore, differential expression of IL1A, IL6 and
IL10-three cytokine genes each displaying> 3.6-fold in-
duction 2 hpi-was no longer observed at the 6 h time
point (although real time qRT-PCR data indicate that IL6
was significantly upregulated at this time point (+2.51-
fold, P ≤ 0.01)). In addition, genes encoding proteins
involved in the MAPK cellular signalling pathway were
not differentially expressed at this time point. These data
suggest that the expression of key macrophage cytokines
and chemokines that drive the inflammatory response to
M. avium subsp. paratuberculosis infection, together
with the MAPK cascade genes that encode signalling
proteins regulating their expression, has largely waned 6
hpi.
It is possible that this attenuated fold-change in
gene expression represents self-regulation of the host
innate response to control the amount of cytokine
and chemokine production during infection, thus
limiting the amount of tissue damage caused during
infection [83]. Interestingly, host cytokine-induced
tissue damage is a mechanism that has been pro-
posed to facilitate dissemination of mycobacterial in-
fection [84]. However, pathogenic mycobacteria also
have the ability to inhibit cytokine and chemokine
production, such as inducing over-expression of anti-
inflammatory cytokines including IL-10, which results
in the abrogation of the host immune response and
enables their persistence within infected macrophages
[60]. Therefore, attenuation of the fold-increase in
cytokine and chemokine expression 6 hpi compared
with the fold-increase in expression of these genes at
the 2 h time point, may reflect differential host- and
pathogen-directed survival strategies during M.
avium subsp. paratuberculosis infection.
Interestingly, two cytosolic PRRs-TLR3 and IFIH1,
whose proteins products are involved with the detec-
tion of viral PAMPs, such as reoviral double-stranded
RNA-were upregulated at the 6 h time point post-infection. This observation is further supported by
inspection of the differentially expressed genes within
the IPA-identified Role of PRRs in the detection of
bacteria and viruses pathway (4th ranked pathway at
the 6 h time point). TLR3 belongs to the TLR family
of PRRs that localises to endosomes-membrane-
bound vesicles inside eukaryotic cells that transport
proteins and lipids from the cells surface and other
organelles to the lysosome for degradation [68].
IFIH1 encodes a cytosolic RIG-I-like receptor (RLR)
RNA helicase that functions as cytoplasmic sensors
of viral RNA [85,86].
The role of these cytosolic PRRs in mediating the macro-
phage response to M. avium subsp. paratuberculosis infec-
tion in vitro is intriguing given their documented roles in
detecting viral PAMPs. One possibility for their induction
following infection is that these PRRs mediate autophagy in
infected macrophages-a complex cellular process in which
host cell cytosolic components such as damaged or surplus
organelles are engulfed in double-membrane vesicles, called
autophagosomes, and fused with late endosomes or
lysosomes to degrade their contents. Burgeoning evidence
supports autophagy as a key host innate defence mechan-
ism against mycobacterial infection, while cytosolic PRRs,
including members of the TLR and RIG-I family of
receptors, have been implicated in regulating this process
[87-91]. Alternatively, it has been proposed that activation
of cytosolic PRRs by intracellular bacterial pathogens may
be due to the translocation of bacterial RNA into host cells,
or is a consequence of the generation of host-derived RNA
ligands caused by the pathogen-mediated disruption of host
cellular pathways during infection [92].
There was a striking reduction in the number of differ-
entially expressed genes at the 24 h time point compared
to that for 2 and 6 hpi. Furthermore, the list of differen-
tially expressed genes at this time point did not include
any cytokine and chemokine genes. These data suggest
that up- and down-regulation of macrophage genes in
response to M. avium subsp. paratuberculosis infection
has largely abated by the 24 h time point, supporting the
hypothesis that changes in macrophage gene expression in
response to M. avium subsp. paratuberculosis infection
in vitro are transient [54,60]. However, among the differ-
entially expressed genes identified 24 hpi with immuno-
logical function associated with mycobacterial infection
was CD40; a macrophage receptor previously shown to be
important for mediating the host response to mycobacter-
ial pathogens.
CD40 encodes member 5 of the TNF-receptor (TNFR)
superfamily of proteins, which is expressed on the sur-
face of macrophages and other antigen presenting cells.
Macrophage activation by antigen-activated T cells occurs
through the binding of CD40 with the CD40 ligand
(CD40L, which is transiently expressed on the surface of
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coding IL-12p40 (IL12B) and NOS (NOS2) [93]. Several
studies have highlighted the importance of CD40 in the
host response to mycobacterial infection. For example,
Sommer et al. [94] demonstrated that bovine MDM
infected with M. avium subsp. paratuberculosis did not
induce IL12B and NOS expression following treatment with
CD40L, suggesting that the pathogen suppresses IL12 and
NOS expression by interfering with CD40-mediated signal-
ling. Also, CD40−/− knockout mice infected with M. avium
were shown to have impaired IL-12 and IFN-γ responses
compared to control mice, suggesting that CD40 is import-
ant for the development of the adaptive immune response
to mycobacterial infection [95].
In the current study, microarray analysis showed that
CD40 was upregulated at all time points post-infection,
while CD40 signalling was the 7th highest ranking canonical
pathways identified 2 hpi, supporting an important role for
this macrophage receptor during M. avium subsp. paratu-
berculosis infection in vitro. IL12B was differentially
expressed (upregulated) in the infected MDM only at the
2 h time point, while NOS2 was upregulated 2 and 6 hpi
and was not differentially expressed at the 24 h time point.
Thus, these findings lend some support to the hypothesis
that M. avium subsp. paratuberculosis infection in vitro
suppresses IL12B and NOS2 expression in MDM via the
CD40 signalling pathway 24 hpi [94].
In conclusion, the results from this study provide further
insight in to the early transcriptomic macrophage response
to M. avium subsp. paratuberculosis infection. In particular,
inspection and systems analysis of the differentially
expressed genes identified several key cellular pathways
involved in the host response to M. avium subsp. paratu-
berculosis, including TLR, MAPK and CD40 signalling
pathways, apoptosis and possibly autophagy. Further ana-
lyses involving the comparison of gene expression changes
in bovine macrophages to other mycobacterial species, such
asM. bovis andM. bovis-BCG, may also highlight the differ-
ential responses of the host macrophage to these pathogens
and enable identification of key cellular pathways that con-
tribute to the development of pathology. Furthermore, the
identification of gene expression patterns linked to infection
and pathology could provide a route to improved diagnos-
tics of Johne’s disease.Additional files
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Additional file 1: Table S1. The real time qRT-PCR primers used in this
study.
Additional file 2: Table S2. The list of differentially expressed
transcripts detected at the 2 h time point post-infection.
Additional file 3: Table S3. Gene ontology (GO) categories identifiedusing IPA at the 2 h time point post-infection. The top ranking GO
categories identified by IPA are listed according to P-values.
Additional file 4: Table S4. Top-ranking canonical pathways identified
using IPA at the 2 h time point post-infection. The top ranking canonical
pathways identified by IPA are listed according to P-values. The ratio
indicates the number of differentially expressed genes involved in each
canonical pathway divided by the total number of genes within each
pathway as per the IPA Knowledge Base.
Additional file 5: Table S5 The list of differentially expressed transcripts
detected at the at the 6 h time point post-infection.
Additional file 6: Table S6 Gene ontology (GO) categories identified
using IPA at the 6 h time point post-infection. The top ranking GO
categories identified by IPA are listed according to P-values.
Additional file 7: Table S7 Top-ranking canonical pathways identified
using IPA at the 6 h time point post-infection. The top ranking canonical
pathways identified by IPA are listed according to P-values. The ratio
indicates the number of differentially expressed genes involved in each
canonical pathway divided by the total number of genes within each
pathway according to the IPA Knowledge Base.
Additional file 8: Table S8 The list of differentially expressed transcripts
detected at the at the 24 h time point post-infection.
Additional file 9: Table S9 Gene ontology (GO) categories identified
using IPA at the 24 h time point post-infection. The top ranking GO
categories identified by IPA are listed according to P-values.
Additional file 10: Table S10 Top-ranking canonical pathways
identified using IPA at the 24 hour time point post-infection. The top
ranking canonical pathways identified by IPA are listed according to P-
values. The ratio indicates the number of differentially expressed genes
involved in each canonical pathway divided by the total number of
genes within each pathway according to the IPA Knowledge Base.
Additional file 11: Table S11 Gene expression profiles for the CCL5,
CCL20 and IL1B genes based on real time qRT-PCR analysis using
conventional and linearly amplified cDNA. Geometric mean fold-changes
of gene expression (infected MDM relative to non-infected control MDM
at each time point) are given for the microarray and real time qRT-PCR
data at each time point. “NS” indicates that the gene was not significantly
differentially expressed at the appropriate time point.
Additional file 12: Figure S1 Comparison of the fold-changes in
expression for the CCL5, CCL20 and IL1B genes based on real time
qRT-PCR analysis using conventional and linearly amplified cDNA. Log2
fold-changes in expression in the M. avium subsp. paratuberculosis-
infected MDM (MPTb) relative to the non-infected control MDM at all
three time points are shown. Linearly amplified cDNA template was
prepared using the WT-Ovation™ RNA Amplification System (see Materials
and Methods section). The significance of the fold-changes in expression
for each gene based on the real time qRT-PCR analysis only are denoted
by asterisks in the figure (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001). In addition,
the log2 fold-change in expression for the non-infected control MDM at
each time point relative to the 0 hour non-infected control MDM are also
shown for both the conventional and linearly amplified cDNA; no
significant differences in gene expression between the non-infected
control MDM relative to the 0 hour non-infected control was observed at
each time point (P ≥ 0.05). Fitted line plots showing the regression
analysis of the log2 fold-change in expression for the cDNA and linearly
amplified cDNA are also presented.
Additional file 13: Figure S2 Real time qRT-PCR analysis. Log2 fold-
changes in expression in the infected MDM relative to the non-infected
control MDM at all three time points are shown. Genes with an “OVA”
suffix indicate that linearly amplified cDNA template was used for the
analysis of these genes. For comparison, the expression profiles for these
genes as per the microarray data are also shown. The significance of the
mean fold-changes in expression for each gene based on the real time
qRT-PCR analysis only are denoted by asterisks in the figure (*P ≤ 0.05,
**P ≤ 0.01, ***P ≤ 0.001). The mean fold-changes calculated for each
gene based on the microarray data in the infected MDM for each gene
are detailed in Table 1. In addition, the log2 fold-change in expression for
the non-infected control MDM at each time point relative to the 0 hour
non-infected control MDM are also shown for both the microarray and
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Competing interests
The authors declare that they have no competing interests.
Acknowledgements
This work was supported by Investigator Grants from Science Foundation
Ireland (Nos: SFI/01/F.1/B028 and SFI/08/IN.1/B2038), a Research Stimulus
Grant from the Department of Agriculture, Fisheries and Food (No: RSF 06
405) and a European Union Framework 7 Project Grant (No: KBBE-211602-
MACROSYS). KEK is supported by the Irish Research Council for Science,
Engineering and Technology (IRCSET) funded Bioinformatics and Systems
Biology PhD Programme. We thank Mr Kevin Kenny, Mr Eamon Costello, and
staff at the Central Veterinary Research Laboratory (CVRL), Backweston, Co.
Kildare for culturing and providing the field isolate of M. avium subsp.
paratuberculosis and the staff at the UCD Lyons Research Farm for assistance
with blood collection. We also thank Prof. Stephen Gordon (UCD) for
valuable comments. Finally, we thank two anonymous reviewers for helpful
comments and insights.
Author details
1Animal Genomics Laboratory, UCD School of Agriculture and Food Science,
University College Dublin, Belfield, Dublin 4, Ireland. 2UCD Conway Institute
of Biomolecular and Biomedical Research, University College Dublin, Belfield,
Dublin 4, Ireland. 3Smurfit Institute of Genetics, Trinity College Dublin, Trinity
College, Belfield, Dublin 2, Ireland. 4Tuberculosis Diagnostics and
Immunology Research Centre, UCD School of Veterinary Medicine, University
College Dublin, Belfield, Dublin 4, Ireland.
Authors’ contributions
Conceived and designed the experiments: DEM, MT, NCN, JAB, EG, DAM.
Performed the experiments: DAM, MT, NCN, JAB. Analysed the data: DAM,
MT, KEK, NCN, JAB, SDEP, KH. Wrote and edited the manuscript: DAM, DEM,
MT, KEK, NCN, KH, EG. All authors read and approved the manuscript.
Received: 14 November 2011 Accepted: 28 March 2012
Published: 28 March 2012
References
1. Coussens PM: Mycobacterium paratuberculosi and the bovine immune
system. Anim Health Res Rev 2001, 2(2):141–161.
2. Over K: Crandall PG, O'Bryan CA. Ricke SC:. Current perspectives on
Mycobacterium avium subsp. paratuberculosis, Johne's disease, and Crohn's
disease: a review. Crit Rev Microbiol 2011, 37(2):141–156.
3. National Research Council (USA) Committee on Diagnosis and Control of
Johne's Disease: Diagnosis and Control of Johne's Disease. Washington, D.C.:
The National Academies Press; 2003.
4. Timms VJ, Gehringer MM, Mitchell HM, Daskalopoulos G: Neilan BA. How
accurately can we detect Mycobacterium avium subsp. paratuberculosis
infection? J Microbiol Methods 2011, 85(1):1–8.
5. Nielsen SS, Toft N: Ante mortem diagnosis of paratuberculosis: a review
of accuracies of ELISA, interferon-gamma assay and faecal culture
techniques. Vet Microbiol 2008, 129(3–4):217–235.
6. Nielsen SS, Toft N: A review of prevalences of paratuberculosis in farmed
animals in Europe. Prev Vet Med 2009, 88(1):1–14.
7. United States Department of Agriculture (USDA) Animal and Plant Health
Inspection Service (APHIS): Johne’s Disease on U.S. Dairies,
1991–2007. USDA-APHIS Report number N521.0408, Edited by
USDA-APHIS, Fort Collins, CO, USA; 2008.
8. Ott SL, Wells SJ, Wagner BA: Herd-level economic losses associated with
Johne's disease on US dairy operations. Prev Vet Med 1999,
40(3–4):179–192.
9. Stabel JR: Johne's disease: a hidden threat. J Dairy Sci 1998,
81(1):283–288.
10. Pierce ES: Where are all the Mycobacterium aviu subspecies
paratuberculosi in patients with Crohn's disease? PLoS Pathog 2009, 5(3):
e1000234.11. Streeter RN, Hoffsis GF, Bech-Nielsen S, Shulaw WP, Rings DM: Isolation of
Mycobacterium paratuberculosi from colostrum and milk of subclinically
infected cows. Am J Vet Res 1995, 56(10):1322–1324.
12. Seitz SE, Heider LE, Heuston WD, Bech-Nielsen S, Rings DM, Spangler L:
Bovine fetal infection with Mycobacterium paratuberculosi. J Am Vet Med
Assoc 1989, 194(10):1423–1426.
13. Coussens PM: Model for immune responses to Mycobacterium aviu
subspecies paratuberculosi in cattle. Infect Immun 2004, 72(6):3089–3096.
14. Momotani E, Whipple DL, Thiermann AB, Cheville NF: Role of M cells and
macrophages in the entrance of Mycobacterium paratuberculosi into
domes of ileal Peyer's patches in calves. Vet Pathol 1988, 25(2):131–137.
15. Weiss DJ: Souza CD. Modulation of mononuclear phagocyte function by
Mycobacterium avium subsp. paratuberculosis. Vet Pathol 2008, 45(6):
829–841.
16. Weiss DJ, Evanson OA, de Souza C, Abrahamsen MS: A critical role of
interleukin-10 in the response of bovine macrophages to infection by
Mycobacterium aviu subsp paratuberculosi. Am J Vet Res 2005, 66(4):
721–726.
17. Coussens PM, Verman N, Coussens MA: Elftman MD. McNulty AM: Cytokine
gene expression in peripheral blood mononuclear cells and tissues of cattle
infected with Mycobacterium avium subsp. paratuberculosis: evidence for an
inherent proinflammatory gene expression pattern. Infect Immun 2004, 72
(3):1409–1422.
18. McKenna SL, Keefe GP, Tiwari A, VanLeeuwen J, Barkema HW: Johne's
disease in Canada part II: disease impacts, risk factors, and
control programs for dairy producers. Can Vet J 2006,
47(11):1089–1099.
19. Tiwari A, VanLeeuwen JA, McKenna SL, Keefe GP, Barkema HW: Johne's
disease in Canada Part I: clinical symptoms, pathophysiology, diagnosis,
and prevalence in dairy herds. Can Vet J 2006, 47(9):874–882.
20. Souza CD: Evanson OA. Weiss DJ: Role of cell membrane receptors in the
suppression of monocyte anti-microbial activity against Mycobacterium avium
subsp. paratuberculosis. Microb Pathog 2008, 44(3):215–223.
21. Tooker BC: Burton JL. Coussens PM: Survival tactics of M.
paratuberculosis in bovine macrophage cells. Vet Immunol Immunopathol
2002, 87(3–4):429–437.
22. Verschoor CP, Pant SD, You Q: Kelton DF. Karrow NA: Gene expression
profiling of PBMCs from Holstein and Jersey cows sub-clinically infected with
Mycobacterium avium ssp. paratuberculosis. Vet Immunol Immunopathol 2010,
137(1–2):1–11.
23. Kabara E, Kloss CC, Wilson M, Tempelman RJ, Sreevatsan S, Janagama H,
Coussens PM: A large-scale study of differential gene expression in
monocyte-derived macrophages infected with several strains of
Mycobacterium aviu subspecies paratuberculosi. Brief Funct Genomics 2010,
9(3):220–237.
24. Murphy JT, Sommer S, Kabara EA, Verman N, Kuelbs MA, Saama P, Halgren
R, Coussens PM: Gene expression profiling of monocyte-derived
macrophages following infection with Mycobacterium aviu subspecies
aviu and Mycobacterium aviu subspecies paratuberculosi. Physiol Genomics
2006, 28(1):67–75.
25. Coussens PM, Colvin CJ, Wiersma K, Abouzied A, Sipkovsky S: Gene
expression profiling of peripheral blood mononuclear cells from cattle
infected with Mycobacterium paratuberculosi. Infect Immun 2002, 70
(10):5494–5502.
26. Jacobsen CN, Aasted B, Broe MK, Petersen JL: Reactivities of 20 anti-human
monoclonal antibodies with leucocytes from ten different animal
species. Vet Immunol Immunopathol 1993, 39(4):461–466.
27. Taraktsoglou M, Szalabska U, Magee DA, Browne JA, Sweeney T, Gormley E,
MacHugh DE: Transcriptional profiling of immune genes in bovine
monocyte-derived macrophages exposed to bacterial antigens. Vet
Immunol Immunopathol 2011, 140(1–2):130–139.
28. Stabel JR: Robbe-Austerman S. Early immune markers associated with
Mycobacterium avium subsp. paratuberculosis infection in a neonatal calf
model. Clin Vaccine Immunol 2011, 18(3):393–405.
29. AffymetrixW GeneChipW Bovine Genome Array: http://media.affymetrix.com/
support/technical/datasheets/bovine_datasheet.pdf
30. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B,
Gautier L, Ge Y, Gentry J, et al: Bioconductor: open software development
for computational biology and bioinformatics. Genome Biol 2004, 5(10):
R80.
31. The R project for statistical computing: http://www.r-project.org
MacHugh et al. Veterinary Research 2012, 43:25 Page 18 of 19
http://www.veterinaryresearch.org/content/43/1/2532. Wilson CL, Miller CJ: Simpleaffy: a BioConductor package for
Affymetrix Quality Control and data analysis. Bioinformatics 2005,
21(18):3683–3685.
33. Hochreiter S, Clevert DA, Obermayer K: A new summarization method for
Affymetrix probe level data. Bioinformatics 2006, 22(8):943–949.
34. Talloen W, Clevert DA, Hochreiter S, Amaratunga D, Bijnens L, Kass S,
Gohlmann HW: I/NI-calls for the exclusion of non-informative genes: a
highly effective filtering tool for microarray data. Bioinformatics 2007, 23
(21):2897–2902.
35. Smyth GK: Linear models and empirical bayes methods for assessing
differential expression in microarray experiments. Stat Appl Genet Mol Biol
2004, 3:Article3.
36. AffymetrixW GeneChipW Bovine Genome Array gene annotation: http://
www.affymetrix.com/estore/support/file_download.affx?onloadforward=/
analysis/downloads/na31/ivt/Bovine.na31.annot.csv.zip
37. Benjamini Y, Hochberg Y: Controlling the False Discovery Rate - a Practical
and Powerful Approach to Multiple Testing. J R Stat Soc Series B Stat
Methodol 1995, 57(1):289–300.
38. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C,
Aach J, Ansorge W, Ball CA, Causton HC, et al: Minimum information about
a microarray experiment (MIAME)-toward standards for microarray data.
Nat Genet 2001, 29(4):365–371.
39. Barrett T, Edgar R: Gene expression omnibus: microarray data storage,
submission, retrieval, and analysis. Methods Enzymol 2006, 411:352–369.
40. Untergasser A, Nijveen H, Rao X, Bisseling T, Geurts R, Leunissen JA:
Primer3Plus, an enhanced web interface to Primer3. Nucleic Acids Res 2007,
35(Web Server issue):W71-74.
41. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J: qBase
relative quantification framework and software for management and
automated analysis of real-time quantitative PCR data. Genome Biol 2007,
8(2):R19.
42. Nicholson S, Bonecini-Almeida Mda G, Lapa e Silva JR, Nathan C, Xie QW,
Mumford R, Weidner JR, Calaycay J, Geng J, Boechat N et al: Inducible nitric
oxide synthase in pulmonary alveolar macrophages from patients with
tuberculosis. J Exp Med 1996, 183(5):2293–2302.
43. Magee DA, Taraktsoglou M, Killick KE, Nalpas NC, Browne JA, Park SDE,
Conlon KM, Lynn DJ, Hokamp K, Gordon SV et al: Global gene expression
and systems biology analysis of bovine monocyte-derived macrophages in
response to in vitro challenge with Mycobacterium bovis. PLoS ONE in press.
44. Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, Canese K, Chetvernin
V, Church DM, Dicuccio M, Federhen S et al: Database resources of the
National Center for Biotechnology Information. Nucleic Acids Res 2012, 40
(Database issue):D13-25.
45. Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, Nativ N,
Bahir I, Doniger T, Krug H et al: GeneCards Version 3: the human gene
integrator. Database (Oxford) 2010, 2010:baq020.
46. Morey JS, Ryan JC, Van Dolah FM: Microarray validation: factors
influencing correlation between oligonucleotide microarrays and real-
time PCR. Biol Proced Online 2006, 8:175–193.
47. Watanabe RM: Statistical issues in gene association studies. Methods Mol
Biol 2011, 700:17–36.
48. Singer JB: Candidate gene association analysis. Methods Mol Biol 2009,
573:223–230.
49. Rice TK, Schork NJ, Rao DC: Methods for handling multiple testing. Adv
Genet 2008, 60:293–308.
50. Widdison S, Watson M, Coffey TJ: Early response of bovine alveolar
macrophages to infection with live and heat-killed Mycobacterium bovi.
Dev Comp Immunol 2011, 35(5):580–591.
51. Silver RF, Walrath J, Lee H, Jacobson BA, Horton H, Bowman MR, Nocka K,
Sypek JP: Human alveolar macrophage gene responses to Mycobacterium
tuberculosi strains H37Ra and H37Rv. Am J Respir Cell Mol Biol 2009, 40
(4):491–504.
52. Tailleux L, Waddell SJ, Pelizzola M, Mortellaro A, Withers M, Tanne A,
Castagnoli PR, Gicquel B, Stoker NG, Butcher PD, et al: Probing host
pathogen cross-talk by transcriptional profiling of both Mycobacterium
tuberculosi and infected human dendritic cells and macrophages. PLoS
ONE 2008, 3(1):e1403.
53. Basler T, Geffers R, Weiss S, Valentin-Weigand P, Goethe R: Mycobacterium
aviu subspecies induce differential expression of pro-inflammatory
mediators in a murine macrophage model: evidence for enhanced
pathogenicity of Mycobacterium aviu subspecies paratuberculosi.
Immunobiology 2008, 213(9–10):879–888.54. Coussens PM, Colvin CJ, Rosa GJ: Perez Laspiur J. Elftman MD: Evidence for a
novel gene expression program in peripheral blood mononuclear cells from
Mycobacterium avium subsp. paratuberculosis-infected cattle. Infect Immun
2003, 71(11):6487–6498.
55. Meade KG, Gormley E, Doyle MB, Fitzsimons T, O'Farrelly C, Costello E, Keane
J, Zhao Y, MacHugh DE: Innate gene repression associated with
Mycobacterium bovi infection in cattle: toward a gene signature of
disease. BMC Genomics 2007, 8:400.
56. Lesho E, Forestiero FJ, Hirata MH, Hirata RD, Cecon L, Melo FF, Paik SH,
Murata Y, Ferguson EW, Wang Z, et al: Transcriptional responses of host
peripheral blood cells to tuberculosis infection. Tuberculosis 2011, 91
(5):390–399.
57. Killick KE, Browne JA, Park SD, Magee DA, Martin I, Meade KG, Gordon SV,
Gormley E, O'Farrelly C, Hokamp K, MacHugh DE: Genome-wide
transcriptional profiling of peripheral blood leukocytes from cattle
infected with Mycobacterium bovi reveals suppression of host immune
genes. BMC Genomics 2011, 12:611.
58. Koul A, Herget T, Klebl B, Ullrich A: Interplay between mycobacteria and
host signalling pathways. Nat Rev Microbiol 2004, 2(3):189–202.
59. Józefowski S, Sobota A, Kwiatkowska K: How Mycobacterium tuberculosi
subverts host immune responses. Bioessays 2008, 30(10):943–954.
60. Weiss DJ, Evanson OA, Moritz A: Deng MQ. Abrahamsen MS: Differential
responses of bovine macrophages to Mycobacterium avium subsp.
paratuberculosis and Mycobacterium avium subsp. avium. Infect Immun 2002,
70(10):5556–5561.
61. Weiss DJ, Souza CD, Evanson OA, Sanders M: Rutherford M. Bovine
monocyte TLR2 receptors differentially regulate the intracellular fate of
Mycobacterium avium subsp. paratuberculosis and Mycobacterium avium
subsp. avium. J Leukoc Biol 2008, 83(1):48–55.
62. Nalubamba K, Smeed J, Gossner A, Watkins C, Dalziel R, Hopkins J:
Differential expression of pattern recognition receptors in the three
pathological forms of sheep paratuberculosis. Microbes Infect 2008, 10
(6):598–604.
63. Harding CV, Boom WH: Regulation of antigen presentation by
Mycobacterium tuberculosi: a role for Toll-like receptors. Nat Rev Microbiol
2010, 8(4):296–307.
64. Kleinnijenhuis J, Oosting M, Joosten LA, Netea MG, Van Crevel R: Innate
immune recognition of Mycobacterium tuberculosi. Clin Dev Immunol 2011,
2011:405310.
65. Sasindran SJ, Torrelles JB: Mycobacterium tuberculosi infection and
inflammation: what is beneficial for the host and for the bacterium?
Front Microbiol 2011, 2:2.
66. Weiss DJ, Souza CD, Evanson OA: Effects of nuclear factor-kappaB on
regulation of cytokine expression and apoptosis in bovine monocytes
exposed to Mycobacterium aviu subsp paratuberculosi. Am J Vet Res 2008,
69(6):804–810.
67. Souza CD, Evanson OA, Weiss DJ: Role of the MAPK(ERK) pathway in
regulation of cytokine expression by Mycobacterium aviu subsp
paratuberculosi-exposed bovine monocytes. Am J Vet Res 2007, 68(6):
625–630.
68. Kawai T, Akira S: The role of pattern-recognition receptors in innate
immunity: update on Toll-like receptors. Nat Immunol 2010, 11(5):373–384.
69. Barton GM, Medzhitov R: Toll-like receptor signaling pathways. Science
2003, 300(5625):1524–1525.
70. Zhang Y, Dong C: Regulatory mechanisms of mitogen-activated kinase
signaling. Cell Mol Life Sci 2007, 64(21):2771–2789.
71. Zhang YL, Dong C: MAP kinases in immune responses. Cell Mol Immunol
2005, 2(1):20–27.
72. Blumenthal A, Ehlers S, Ernst M, Flad HD, Reiling N: Control of
mycobacterial replication in human macrophages: roles of extracellular
signal-regulated kinases 1 and 2 and p38 mitogen-activated protein
kinase pathways. Infect Immun 2002, 70(9):4961–4967.
73. Souza CD: Evanson OA. Weiss DJ: Role of the mitogen-activated protein
kinase pathway in the differential response of bovine monocytes to
Mycobacterium avium subsp. paratuberculosis and Mycobacterium avium
subsp. avium. Microbes Infect 2007, 9(14–15):1545–1552.
74. Reiling N, Blumenthal A, Flad HD, Ernst M, Ehlers S: Mycobacteria-induced
TNF-alpha and IL-10 formation by human macrophages is differentially
regulated at the level of mitogen-activated protein kinase activity. J
Immunol 2001, 167(6):3339–3345.
75. Romano MF, Lamberti A, Petrella A, Bisogni R, Tassone PF, Formisano S,
Venuta S, Turco MC: IL-10 inhibits nuclear factor-kappa B/Rel nuclear
MacHugh et al. Veterinary Research 2012, 43:25 Page 19 of 19
http://www.veterinaryresearch.org/content/43/1/25activity in CD3-stimulated human peripheral T lymphocytes. J Immunol
1996, 156(6):2119–2123.
76. Haddad JJ, Saade NE, Safieh-Garabedian B: Interleukin-10 and the
regulation of mitogen-activated protein kinases: are these signalling
modules targets for the anti-inflammatory action of this cytokine? Cell
Signal 2003, 15(3):255–267.
77. Elass E, Coddeville B, Kremer L, Mortuaire M, Mazurier J, Guerardel Y:
Mycobacterial lipomannan induces MAP kinase phosphatase-1
expression in macrophages. FEBS Lett 2008, 582(3):445–450.
78. Behar SM, Martin CJ, Booty MG, Nishimura T, Zhao X, Gan HX, Divangahi M,
Remold HG: Apoptosis is an innate defense function of macrophages
against Mycobacterium tuberculosi. Mucosal Immunol 2011, 4(3):279–287.
79. Keane J, Balcewicz-Sablinska MK, Remold HG, Chupp GL, Meek BB, Fenton
MJ, Kornfeld H: Infection by Mycobacterium tuberculosi promotes human
alveolar macrophage apoptosis. Infect Immun 1997, 65(1):298–304.
80. Schaible UE, Winau F, Sieling PA, Fischer K, Collins HL, Hagens K, Modlin RL,
Brinkmann V, Kaufmann SH: Apoptosis facilitates antigen presentation to T
lymphocytes through MHC-I and CD1 in tuberculosis. Nat Med 2003, 9
(8):1039–1046.
81. Behar SM, Divangahi M, Remold HG: Evasion of innate immunity by
Mycobacterium tuberculosi: is death an exit strategy? Nat Rev Microbiol
2010, 8(9):668–674.
82. Kelly DM, ten Bokum AM, O'Leary SM, O'Sullivan MP, Keane J: Bystander
macrophage apoptosis after Mycobacterium tuberculosi H37Ra infection.
Infect Immun 2008, 76(1):351–360.
83. Widdison S, Schreuder LJ, Villarreal-Ramos B, Howard CJ, Watson M, Coffey
TJ: Cytokine expression profiles of bovine lymph nodes: effects of
Mycobacterium bovi infection and bacille Calmette-Guerin vaccination.
Clin Exp Immunol 2006, 144(2):281–289.
84. Russell DG: Mycobacterium tuberculosi and the intimate discourse of a
chronic infection. Immunol Rev 2011, 240(1):252–268.
85. Yu M, Levine SJ: Toll-like receptor, RIG-I-like receptors and the NLRP3
inflammasome: key modulators of innate immune responses to double-
stranded RNA viruses. Cytokine Growth Factor Rev 2011, 22(2):63–72.
86. Loo YM, Gale M Jr: Immune signaling by RIG-I-like receptors. Immunity
2011, 34(5):680–692.
87. Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS, Iwasaki A: Absence of
autophagy results in reactive oxygen species-dependent amplification of
RLR signaling. Proc Natl Acad Sci U S A 2009, 106(8):2770–2775.
88. Delgado MA, Elmaoued RA, Davis AS, Kyei G, Deretic V: Toll-like receptors
control autophagy. The EMBO journal 2008, 27(7):1110–1121.
89. Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V:
Autophagy is a defense mechanism inhibiting BCG and Mycobacterium
tuberculosi survival in infected macrophages. Cell 2004, 119(6):753–766.
90. Levine B, Deretic V: Unveiling the roles of autophagy in innate and
adaptive immunity. Nat Rev Immunol 2007, 7(10):767–777.
91. Deretic V: Autophagy in immunity and cell-autonomous defense against
intracellular microbes. Immunol Rev 2011, 240(1):92–104.
92. Monroe KM, McWhirter SM, Vance RE: Identification of host cytosolic
sensors and bacterial factors regulating the type I interferon response to
Legionella pneumophila. PLoS Pathog 2009, 5(11):e1000665.
93. van Kooten C, Banchereau J: CD40-CD40 ligand. J Leukoc Biol 2000,
67(1):2–17.
94. Sommer S, Pudrith CB, Colvin CJ, Coussens PM: Mycobacterium aviu
subspecies paratuberculosi suppresses expression of IL-12p40 and iNOS
genes induced by signalling through CD40 in bovine monocyte-derived
macrophages. Vet Immunol Immunopathol 2009, 128(1–3):44–52.
95. Florido M, Goncalves AS, Gomes MS, Appelberg R: CD40 is required for the
optimal induction of protective immunity to Mycobacterium aviu.
Immunology 2004, 111(3):323–327.
doi:10.1186/1297-9716-43-25
Cite this article as: MacHugh et al.: Pan-genomic analysis of bovine
monocyte-derived macrophage gene expression in response to in vitro
infection with Mycobacterium avium subspecies paratuberculosis. Veterinary
Research 2012 43:25.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
